79225147 - ASCENDIS PHARMA

Information

  • Trademark
  • 79225147
  • Serial Number
    79225147
  • Registration Number
    6630735
  • Filing Date
    October 11, 2017
    6 years ago
  • Registration Date
    February 01, 2022
    2 years ago
  • Transaction Date
    August 01, 2022
    a year ago
  • Status Date
    February 01, 2022
    2 years ago
  • Published for Opposition Date
    November 16, 2021
    2 years ago
  • Location Date
    February 01, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SHOOR, AMIT KUMAR
  • Attorney Docket Number
    tbd
    Attorney Name
    Eric T. Fingerhut
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
3000
Mark Identification
ASCENDIS PHARMA
Case File Statements
  • DM0000: The mark consists of the turquoise word "ASCENDIS" under which is the grey word "PHARMA" next to a polygon broken by a white curved band in which the top is turquoise and the bottom is blue.
  • GS0051: Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
  • CC0000: The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark.
  • GS0451: Licensing of industrial property; legal services
  • D10000: "PHARMA"
  • GS0421: Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
Case File Event Statements
  • 8/1/2022 - a year ago
    73 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/13/2022 - a year ago
    72 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/13/2022 - a year ago
    71 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 5/1/2022 - 2 years ago
    70 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/1/2022 - 2 years ago
    69 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/24/2021 - 2 years ago
    68 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 11/23/2021 - 2 years ago
    67 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 11/16/2021 - 2 years ago
    66 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/16/2021 - 2 years ago
    65 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/28/2021 - 2 years ago
    64 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/27/2021 - 2 years ago
    63 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/27/2021 - 2 years ago
    62 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/27/2021 - 2 years ago
    61 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/13/2021 - 2 years ago
    60 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/12/2021 - 2 years ago
    59 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/12/2021 - 2 years ago
    58 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/12/2021 - 2 years ago
    57 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 7/9/2021 - 2 years ago
    56 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 7/9/2021 - 2 years ago
    55 - FINAL REFUSAL E-MAILED Type: GNFR
  • 7/9/2021 - 2 years ago
    54 - FINAL REFUSAL WRITTEN Type: CNFR
  • 6/10/2021 - 3 years ago
    53 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2021 - 3 years ago
    52 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/15/2021 - 3 years ago
    51 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/15/2021 - 3 years ago
    50 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/15/2021 - 3 years ago
    49 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/15/2021 - 3 years ago
    48 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/15/2021 - 3 years ago
    47 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 3/15/2021 - 3 years ago
    46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/15/2021 - 3 years ago
    45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/15/2021 - 3 years ago
    44 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/15/2021 - 3 years ago
    43 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/15/2021 - 3 years ago
    42 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR
  • 3/15/2021 - 3 years ago
    41 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 3/15/2021 - 3 years ago
    40 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/15/2021 - 3 years ago
    39 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/14/2020 - 3 years ago
    38 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/14/2020 - 3 years ago
    37 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2020 - 3 years ago
    36 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/18/2020 - 4 years ago
    35 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 6/3/2020 - 4 years ago
    34 - ASSIGNED TO LIE Type: ALIE
  • 11/21/2019 - 4 years ago
    33 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 7/5/2019 - 4 years ago
    32 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 6/19/2019 - 5 years ago
    31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 6/19/2019 - 5 years ago
    30 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 5/9/2019 - 5 years ago
    29 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 10/19/2018 - 5 years ago
    28 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/19/2018 - 5 years ago
    27 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/19/2018 - 5 years ago
    26 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 10/1/2018 - 5 years ago
    25 - DATA MODIFICATION COMPLETED Type: DMCC
  • 9/28/2018 - 5 years ago
    24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/27/2018 - 5 years ago
    23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/27/2018 - 5 years ago
    22 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/14/2018 - 5 years ago
    21 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/14/2018 - 5 years ago
    20 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/14/2018 - 5 years ago
    19 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/17/2018 - 5 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/17/2018 - 5 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/16/2018 - 5 years ago
    16 - ASSIGNED TO LIE Type: ALIE
  • 7/26/2018 - 5 years ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/24/2018 - 5 years ago
    14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/24/2018 - 5 years ago
    13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/2/2018 - 6 years ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/9/2018 - 6 years ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/9/2018 - 6 years ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/7/2018 - 6 years ago
    9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/6/2018 - 6 years ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/2/2018 - 6 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR
  • 1/30/2018 - 6 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/29/2018 - 6 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/23/2018 - 6 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/19/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/19/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/18/2018 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR